Environmental flame retardant EHDPP stabilizes EGFR to accelerate lung cancer progression: Integrated network toxicology, bioinformatics, and in vitro evidence.
1/5 보강
As a typical organophosphate flame retardant, 2-ethylhexyl diphenyl phosphate (EHDPP) is widely present in the environment through inhalation exposure, but its mechanism in promoting lung cancer progr
APA
Ding K, Bai L, et al. (2026). Environmental flame retardant EHDPP stabilizes EGFR to accelerate lung cancer progression: Integrated network toxicology, bioinformatics, and in vitro evidence.. Ecotoxicology and environmental safety, 311, 119854. https://doi.org/10.1016/j.ecoenv.2026.119854
MLA
Ding K, et al.. "Environmental flame retardant EHDPP stabilizes EGFR to accelerate lung cancer progression: Integrated network toxicology, bioinformatics, and in vitro evidence.." Ecotoxicology and environmental safety, vol. 311, 2026, pp. 119854.
PMID
41671956 ↗
Abstract 한글 요약
As a typical organophosphate flame retardant, 2-ethylhexyl diphenyl phosphate (EHDPP) is widely present in the environment through inhalation exposure, but its mechanism in promoting lung cancer progression remains unclear. This study integrates network toxicology, molecular docking, tumor bioinformatics analysis, and in vitro cell models to systematically investigate the molecular carcinogenic network of EHDPP. First, the potential toxicity of EHDPP was predicted using PROTox and ADMETlab toxicity prediction platforms. Multi-database integration and screening identified 355 potential targets associated with EHDPP-induced lung cancer. KEGG pathway and GO functional enrichment analyses revealed that these key genes were significantly enriched in positive regulation of cell migration, metabolic pathways, and the PI3K-AKT signaling pathway. Further analysis using STRING and Cytoscape software identified 20 core targets, including MAPK14, AKT1, RXRA, PTK2, PTPN11, and EGFR. By integrating core gene expression and prognostic data, four genes-EGFR, RAC1, RXRA, and HRAS-were identified as key molecular hubs potentially regulating EHDPP-driven malignant phenotypes in lung cancer. Analysis of publicly available scRNA-seq data revealed high expression of these four hub genes in immune-related cells as well as AT2 cells, suggesting their potential roles in lung cancer. Molecular docking confirmed moderate predicted binding affinity, suggesting potential interactions between EHDPP and core targets. Additionally, cell model experiments demonstrated that EHDPP significantly promotes the proliferation and migration of lung cancer cells via the PI3K-AKT signaling pathway. Mechanistically, EHDPP binds to EGFR and inhibits its ubiquitination-mediated degradation, thereby stabilizing EGFR protein and partly activating the downstream PI3K-AKT signaling pathway, which ultimately promotes lung cancer cell proliferation and migration. This study is the first to elucidate the molecular mechanism underlying the pro-carcinogenic effects of EHDPP at the interaction level, providing potential molecular marker clues and mechanistic basis for EHDPP-related environmental risk assessment.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Multifunctional DNA nanoplatform based on near-infrared AgInS QDs and rolling circle amplification for fluorescence imaging and therapy of breast cancer cells.
- MARCO macrophages drive immunosuppressive remodeling and metastasis in chemotherapy-associated steatohepatitis.
- Development and validation of an MRI radiomics-based model for predicting progression risk in prostate cancer after endocrine therapy.
- Bioinformatics analysis and experimental studies reveal KPNA2 as a novel biomarker of hepatocellular carcinoma progression and telomere maintenance.
- Clinicopathologic features and therapeutic outcomes in EGFR/ALK-aberrations NSCLC with histologic transformation.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.